Len Blavatnik's Net Worth
$14.4 Billion
Who is Len Blavatnik?
Len Blavatnik has an estimated net worth of $14.4 Billion. This is based on reported shares across multiple companies, which include LyondellBasell Industries N.V., Warner Music Group Corp., Square, Inc., Day One Biopharmaceuticals, Inc., Eliem Therapeutics, Inc., Gamida Cell Ltd., DigitalOcean Holdings, Inc., Neon Therapeutics, Inc., Loxo Oncology, Inc., EP Energy Corp, Anchiano Therapeutics Ltd., Verona Pharma plc, Disc Medicine, Inc., Pandion Therapeutics Holdco LLC, and VYNE Therapeutics Inc..
SEC CIK
Len Blavatnik's CIK is 0001326628
Past Insider Trading and Trends
2018 was Len Blavatnik's most active year for acquiring shares with 22 total transactions. Len Blavatnik's most active month to acquire stocks was the month of October. 2021 was Len Blavatnik's most active year for disposing of shares, totalling 93 transactions. Len Blavatnik's most active month to dispose stocks was the month of January. 2011 saw Len Blavatnik paying a total of $962,666,880.00 for 34,380,960 shares, this is the most they've acquired in one year. In 2020 Len Blavatnik cashed out on 178,634,046 shares for a total of $1,849,173,971.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
LyondellBasell Industries N.V. (LYB) Snapshot price: $94.605
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.26% | -20.85K |
—
|
—
| 204.25K |
Feb 27
| |||
Form 4
| -3.48% | -205.02K |
$97.89 | -$20,069,550.40 | 5.69M |
Feb 16
| |||
Form 4
| -1.02% | -450.00K |
$99.61 | -$648,549.87 | 43.49M |
Aug 10 - Aug 11
| |||
Form 4
| -28.51% | -761.00K |
—
|
—
| 1.91M |
May 11
| |||
Form 4
| -1.47% | -1.43M |
$84.93 | -$121,302,237.00 | 95.71M |
Dec 1 - Dec 2
| |||
Form 4
| -0.93% | -1.40M |
$84.95 | -$119,142,531.75 | 148.68M |
Nov 28 - Nov 30
| |||
Form 4/A
| -0.00% | -27.00 |
$86.47 | -$2,334.75 | 767.08K |
Nov 15
| |||
Form 4
| -0.25% | -127.44K |
$86.48 | -$11,020,939.55 | 50.7M |
Nov 15
| |||
Form 4
| -5.82% | -249.60K |
$77.84 | $311,344.00 | 4.04M |
Jun 13 - Nov 1
| |||
Form 4
| -1.78% | -927.00K |
$108.11 | -$100,214,881.23 | 51.01M |
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
| 9.97M |
Mar 5
| |||
Form 4
| -1.84% | -975.29K |
$106.63 | -$100,763,116.76 | 51.93M |
Mar 1
| |||
Form 4
| -0.01% | -4.50K |
$107.35 | -$483,062.85 | 42.28M |
Feb 25
| |||
Form 4
| -1.66% | -714.50K |
$106.45 | -$76,055,546.94 | 42.28M |
Feb 24
| |||
Form 4
| -1.10% | -478.06K |
$103.10 | -$49,290,137.27 | 42.99M |
Feb 23
| |||
Form 4
| -0.80% | -350.00K |
$103.38 | -$36,182,940.80 | 43.47M |
Feb 22
| |||
Form 4
| -0.72% | -393.78K |
$95.61 | -$37,649,512.58 | 54.46M |
Feb 12
| |||
Form 4
| -0.10% | -55.54K |
$95.41 | -$5,298,797.27 | 54.85M |
Feb 11
| |||
Form 4
| -1.30% | -720.68K |
$95.84 | -$69,068,414.23 | 54.91M |
Feb 10
| |||
Form 4
| -0.92% | -518.69K |
$88.59 | -$45,948,397.85 | 55.63M |
Dec 4
| |||
Form 4
| -3.07% | -1.78M |
$86.10 | -$153,158,295.38 | 56.15M |
Dec 1 - Dec 3
| |||
Form 4
| -0.02% | -10.80K |
$86.63 | -$935,912.70 | 57.92M |
Mar 18 - Nov 30
| |||
Form 4
| +14.99% | 764.5K |
$74.61 | $57,042,266.52 | 5.86M |
Aug 29 - Sep 3
| |||
Form 4
| +75.08% | 2.19M |
$95.60 | $209,076,199.29 | 5.1M |
Nov 9 - Nov 13
| |||
Form 4
| +122.27% | 1.6M |
$95.65 | $153,273,195.20 | 2.91M |
Nov 6 - Nov 8
| |||
Form 4
|
∞
| 1.31M |
$92.35 | $121,035,734.74 | 1.31M |
Nov 1 - Nov 5
| |||
Form 4
| -1.26% | -139.62K |
$89.12 | -$12,441,968.95 | 10.93M |
Mar 9
| |||
Form 4
| -1.10% | -246.21K |
$93.91 | -$23,190,676.84 | 22.17M |
Mar 1 - Mar 2
| |||
Form 4
| -0.13% | -14.17K |
$94.55 | -$1,339,858.13 | 11.31M |
Feb 22
| |||
Form 4
| -4.73% | -1.17M |
$92.35 | -$107,794,649.63 | 23.51M |
Feb 10 - Feb 13
| |||
Form 4
| -4.13% | -3.03M |
$92.60 | -$279,764,583.40 | 70.43M |
Feb 7 - Feb 9
| |||
Form 4
| -3.40% | -4.50M |
$82.29 | -$172,829,186.66 | 127.82M |
Mar 8 - Mar 9
| |||
Form 4
| -2.77% | -4.00M |
$92.33 | -$369,402,020.02 | 140.25M |
Oct 28 - Oct 30
| |||
Form 4
| -2.56% | -4.00M |
$102.54 | -$409,147,898.37 | 152.17M |
Jun 2 - Jun 3
| |||
Form 4
| +13.29% | 8.5M |
$67.71 | $575,535,000.00 | 72.46M |
Jul 31
| |||
Form 4
| -11.06% | -23.03K |
$44.02 | -$1,013,722.23 | 185.24K |
Feb 24
| |||
Form 4
| -11.06% | -9.98M |
$44.01 | -$439,060,650.98 | 80.26M |
Feb 14 - Feb 15
| |||
Form 4
|
—
|
0
|
$28.00 |
—
| 90.11M |
Feb 22
| |||
Form 4
| +61.09% | 34.17M |
$28.00 | $956,835,544.00 | 90.11M |
Jan 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Warner Music Group Corp. (WMG) Snapshot price: $36.11
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
$40.66 | -$348,151,250.00 |
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
$41.25 | -$171,630,731.25 |
0
|
Dec 8
| |||
Form 4
|
—
|
0
|
$43.73 | -$102,328,200.00 |
0
|
Sep 24
| |||
Form 4
|
—
|
0
|
$37.75 | -$118,922,768.00 |
0
|
Sep 8
| |||
Form 4
|
—
|
0
|
$38.25 | -$181,864,444.50 |
0
|
Feb 10
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
$25.00 | -$280,222,025.00 |
0
|
Jul 7
| |||
Form 4
|
—
|
0
|
$25.00 | -$1,368,146,875.00 |
0
|
Jun 2 - Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 3.53M |
—
|
—
| 3.53M |
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Square, Inc. (SQ) Snapshot price: $68.505
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Day One Biopharmaceuticals, Inc. (DAWN) Snapshot price: $15.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +12.88% | 1.48M |
$10.15 | $14,978,327.49 | 12.93M |
Oct 18 - Oct 20
| |||
Form 4
| +7.20% | 769.23K |
$13.00 | $9,999,990.00 | 11.45M |
Jun 9
| |||
Form 4
| +12.65% | 1.2M |
$15.00 | $18,000,000.00 | 10.68M |
Jun 17
| |||
Form 4
| +1.14% | 106.86K |
$14.52 | $1,551,908.53 | 9.48M |
Jan 18 - Jan 20
| |||
Form 4
|
∞
| 9.38M |
$16.00 |
—
| 9.38M |
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Eliem Therapeutics, Inc. (ELYM) Snapshot price: $2.95
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.01M |
$12.50 | $10,000,000.00 | 5.01M |
Aug 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |